News|Articles|October 1, 2006

Pipeline Preview (October 2006)

Dalteparin (Fragmin, Pfizer) for the extended treatment of symptomatic venous thromboembolism (proximal deep vein thrombosis and/or pulmonary embolus) to prevent recurrent venous thromboembolism in patients with cancer

Recommendations for approval

Recommendations against approval

Nonapprovable designations


Latest CME